InvestorsHub Logo
Post# of 24568
Next 10
Followers 90
Posts 2816
Boards Moderated 0
Alias Born 01/22/2006

Re: None

Thursday, 01/27/2011 2:17:52 PM

Thursday, January 27, 2011 2:17:52 PM

Post# of 24568
DSCI $7.25/$7.35 ONLY 1m Float ,, a10shun fdea Playurz,,
FDA MegaPlay Hugh Fruntlode now in Progress for nexxxxt weakz Fireworxxxx ,,

wanna gitt payyd with tha PLayurz? Then ynot cum join tha Free Munny Party.. at DSCI,, now in tha Undrrr $7.5

/// L-O-A-D-I-N-G Z-O-N-E ////

Ovrr 9 iz Blu Sky

10 iz tha Targitt

Lookit i wuz skeptikal too, Butt Herez tha "Inside Informashun" that Was just leekt last nite on Yahoo,, With Only 1m Flote U Know Sum Hedgiez rr Jonezing fo an Ezmunny 25%%-50%% Payout nexxxxt weak,, nn rr Bakking Up tha Trukk today nn Tomorrow:

Response from DSCI regarding timing of DSC127 Results 26-Jan-11 04:16 pm We are close to big News .Fasten your seat belts !
..................................................... ............

At this point we are expecting to get data by the last day of this month (either this Friday or the following Monday). We are told from our stats provider that there will still be some review time necessary before all the data is fully understood to the point where we can make a comprehensive announcement.

I suspect this process will take several days. So, my expectation is that we will have a release out towards the end of the first week in February. It is possible it could take a couple of days longer and go into the following week. It is also possible that we get the data a few days early and then get an announcement out on or before the last day in January. Either way, we are within a very short timeframe in which we will find out the efficacy results of the study.

Again, thanks for the interest. Please feel free to reach out to me if there is additional info I can provide for you.

Best regards,
Barry

Barry Wolfenson, Derma Sciences, Inc.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.